Parasites and Vector Research Unit (PAVRU), Department of Microbiology and Parasitology, University of Buea, P.O. Box 63, Buea, Cameroon.
Research Foundation in Tropical Diseases and Environment (REFOTDE), P.O. Box 474, Buea, Cameroon.
BMC Infect Dis. 2020 Oct 2;20(1):726. doi: 10.1186/s12879-020-05444-2.
Ivermectin is an excellent microfilaricide against Onchocerca volvulus. However, in some regions, long term use of ivermectin has resulted in sub-optimal responses to the treatment. More data to properly document the phenomenon in various contexts of ivermectin mass drug administration (IVM-MDA) is needed. Also, there is a need to accurately monitor a possible repopulation of skin by microfilariae following treatment. Skin snip microscopy is known to have a low sensitivity in individuals with light infections, which can be the case following treatment. This study was designed with two complementary objectives: (i) to assess the susceptibility of O. volvulus microfilariae to ivermectin in two areas undergoing IVM-MDA for different lengths of time, and (ii) to document the repopulation of skin by the O. volvulus microfilariae following treatment, using 3 independent diagnostic techniques.
Identified microfilaridermic individuals were treated with ivermectin and re-examined after 1, 3, and 6 months using microscopy, actin real-time PCR (actin-qPCR) and O-150 LAMP assays. Susceptibility to ivermectin and trends in detecting reappearance of skin microfilariae were determined using three techniques. Microscopy was used as an imperfect gold standard to determine the performance of actin-qPCR and LAMP.
In Bafia with over 20 years of IVM-MDA, 11/51 (21.6%) direct observe treated microfilaridemic participants were still positive for skin microfilariae after 1 month. In Melong, with 10 years of IVM-MDA, 2/29 (6.9%) treated participants were still positive. The microfilarial density reduction per skin biopsy within one month following treatment was significantly lower in participants from Bafia. In both study sites, the molecular techniques detected higher proportions of infected individuals than microscopy at all monitoring time points. LAMP demonstrated the highest levels of sensitivity and real-time PCR was found to have the highest specificity.
Patterns in skin mirofilariae clearance and repopulation were established. O. volvulus worms from Bafia with higher number of annual MDA displayed a lower clearance and higher repopulation rate after treatment with ivermectin. Molecular assays displayed higher sensitivity in monitoring O. volvulus microfilaridemia within six months following treatment.
伊维菌素是一种治疗盘尾丝虫病的极好的微丝蚴药物。然而,在一些地区,长期使用伊维菌素导致对治疗的反应不理想。需要更多的数据来正确记录在各种伊维菌素大规模药物管理(IVM-MDA)环境中出现的现象。此外,还需要准确监测治疗后微丝蚴可能重新在皮肤中繁殖。皮肤划痕显微镜检查在轻度感染的个体中灵敏度较低,这可能是治疗后的情况。这项研究有两个互补的目标:(i)评估在接受 IVM-MDA 治疗不同时间的两个地区,盘尾丝虫微丝蚴对伊维菌素的敏感性;(ii)使用 3 种独立的诊断技术记录治疗后盘尾丝虫微丝蚴对皮肤的重新定殖。
鉴定为微丝蚴性皮炎的个体用伊维菌素治疗,然后在 1、3 和 6 个月时用显微镜、肌动蛋白实时 PCR(actin-qPCR)和 O-150 LAMP 检测重新检查。使用 3 种技术确定伊维菌素的敏感性和检测皮肤微丝蚴重新出现的趋势。显微镜作为不完美的金标准,用于确定 actin-qPCR 和 LAMP 的性能。
在接受了超过 20 年 IVM-MDA 的巴菲亚,51 名直接观察治疗过的微丝蚴血症患者中,11 名(21.6%)在 1 个月后仍为皮肤微丝蚴阳性。在接受了 10 年 IVM-MDA 的梅隆,29 名治疗参与者中(6.9%)有 2 名仍为阳性。治疗后一个月内,每个皮肤活检中微丝蚴密度的减少量在巴菲亚的参与者中明显较低。在这两个研究地点,分子技术在所有监测时间点都比显微镜检测到更高比例的感染个体。LAMP 显示出最高的灵敏度,而实时 PCR 被发现具有最高的特异性。
确立了皮肤微丝蚴清除和重新定殖的模式。来自巴菲亚的感染盘尾丝虫数量较多的个体,在接受伊维菌素治疗后,其微丝蚴清除率较低,重新定殖率较高。分子检测在治疗后 6 个月内监测盘尾丝虫微丝蚴血症的灵敏度更高。